Table 1. Characteristics of patients.
| Characteristics | n | (%) | FOXO4 | |||
|---|---|---|---|---|---|---|
| Low | High | P value | ||||
| Age (years) | ≤ 60 | 113 | (54) | 97 | 16 | |
| > 60 | 98 | (46) | 77 | 21 | 0.204 | |
| Sex | Male | 126 | (60) | 110 | 16 | |
| Female | 85 | (40) | 64 | 21 | 0.028 | |
| Performance status | ECOG 0/1 | 190 | (90) | 161 | 29 | |
| ECOG ≥2 | 21 | (10) | 13 | 8 | 0.015 | |
| Ann Arbor stage | I/II | 140 | (66) | 121 | 19 | |
| III/IV | 71 | (34) | 53 | 18 | 0.037 | |
| Serum LDH | Normal | 134 | (64) | 118 | 16 | |
| Increased | 77 | (36) | 56 | 21 | 0.008 | |
| B symptoms | Absence | 172 | (82) | 140 | 32 | |
| Presence | 39 | (18) | 34 | 5 | 0.489 | |
| Bone marrow involvement | Absence | 197 | (93) | 164 | 33 | |
| Presence | 14 | (7) | 10 | 4 | 0.276 | |
| Extranodal involvement | 0/1 | 165 | (78) | 142 | 23 | |
| ≥ 2 | 46 | (22) | 32 | 14 | 0.015 | |
| IPI | L / LI | 164 | (78) | 142 | 22 | |
| HI / high | 47 | (22) | 32 | 15 | 0.008 | |